Episode 15 - Conference Briefs: Highlighting Myelofibrosis Clinical Data from Key Conferences - Part 3: Emerging novel agents in MF

This Conversations in MF podcast will discuss the most clinically relevant data and emerging strategies into practice to improve outcomes for patients with MF presented from the 2023 international meetings of the American Society of Clinical Oncology (ASCO), European Hematology Association (EHA) and Society of Hematologic Oncology (SOHO).Launch Date: January 29, 2024Release Date: January 29, 2024Expiration Date: December 30, 2024FACULTY BIOSPrithviraj Bose, MDProfessor, Department of Leukemia, Division of Cancer MedicineUniversity of TexasMD Anderson Cancer CenterJohn Mascarenhas, MDProfessor of MedicineIcahn School of Medicine at Mount SinaiDirector, Center of Excellence in Blood Cancers and Myeloid DisordersRuben Mesa, MDExecutive DirectorAtrium Health Wake Forest Baptist Comprehensive Cancer CenterThis podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.https://www.practicepointcme.com/CMEHome/conference-briefs-highlighting-myelofibrosis-clinical-data-from-key-conferences-17